missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. 18192233

IMP2/IGF2BP2 Antibody (OTI3F9), HRP, Novus Biologicals™

Mouse Monoclonal Antibody

Brand:  Novus Biologicals NBP2-71615H

Product Code. 18192233

  • € 782.00 / 0.10mL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

IMP2/IGF2BP2 Monoclonal specifically detects IMP2/IGF2BP2 in Human, Mouse, Rat, Canine, Monkey samples. It is validated for Western Blot, Immunohistochemistry.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

IMP2/IGF2BP2
Monoclonal
HRP
PBS with No Preservative
IGF2BP2
Full length recombinant protein of human IMP2/IGF2BP2 (NP_006333) produced in HEK293T cells.
0.1 mL
Primary
Human, Mouse, Rat, Canine, Monkey
IgG1
Western Blot, Immunohistochemistry
OTI3F9
Western Blot, Immunohistochemistry
Hepatocellular carcinoma autoantigen p62, IGF-II mRNA-binding protein 2, IMP-2IGF2 mRNA-binding protein 2, IMP2VICKZ family member 2, insulin-like growth factor 2 mRNA binding protein 2, insulin-like growth factor 2 mRNA-binding protein 2, p62, VICKZ2
Mouse
Affinity Purified
Cancer, Chromatin Research, Immune System Diseases, Immunology, Transcription Factors and Regulators
10644.0
Store at 4°C in the dark.
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.